Auro Laboratories Reports Decline in Sales and Profitability for May 2025 Results

Auro Laboratories, a microcap company in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending March 2025. The results, declared on May 30, 2025, indicate notable challenges in the company's performance. The financial data reveals that net sales for the latest six months reached Rs 10.45 crore, reflecting a significant decline compared to the previous year. Similarly, the profit after tax (PAT) for the same period was recorded at Rs 0.44 crore, also showing a substantial decrease year on year. These figures suggest a concerning trend in both sales and profitability for Auro Laboratories. In light of these results, there has been an adjustment in the evaluation of the stock, with the score shifting to -12 from -21 over the past three months. This revision highlights the ongoing difficulties faced by the company in the current market environment. For those interested in tracking the evolving financial landscape of Auro Laboratories, further insights can be found here: Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.